News

June 21, 2019 – Canon Medical Systems USA Inc. is showcasing its new line of ultrasound systems, the Aplio a-series, at ...

Home June 21, 2019
Home
Videos | Wearables

Jacques Kpodonu, M.D., FACC, cardiac surgeon, Beth Israel Deaconess Medical Center, and professor at Harvard Medical ...

Home June 21, 2019
Home
ASE will showcase the most recent technology advances in cardiac ultrasound. Photo courtesy of Philips Healthcare.
Feature | Cardiovascular Ultrasound

June 21, 2019 – From a breaking trial of 3-D interoperability to demonstrations of artificial intelligence (AI) ...

Home June 21, 2019
Home
Videos | Atrial Fibrillation

Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of ...

Home June 21, 2019
Home
News | Cath Lab

VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter Cardiovascular Therapeutics (TCT) and the VEITHsymposium. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. VEITHsymposium is the leading global conference covering all aspects of vascular medicine, vascular surgery and endovascular intervention.

Home June 20, 2019
Home
Videos | Virtual and Augmented Reality

David M. Axelrod, M.D., clinical associate professor in pediatrics (cardiology) at Stanford School of Medicine, explains ...

Home June 20, 2019
Home
Videos | Artificial Intelligence

John Rumsfeld, M.D., Ph.D., FACC, American College Cardiology (ACC) chief innovation officer, and professor of medicine ...

Home June 20, 2019
Home
News | Artificial Intelligence

June 20, 2019 — Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational ...

Home June 20, 2019
Home
News | Computed Tomography (CT)

A new type of care for cardiac patients at St. Paul’s Hospital, Vancouver, has the potential to reduce heart imaging wait times, ease emergency department congestion and lower the number of unnecessary hospital admissions. At the center of the new approach is a dedicated cardiac computed tomography (CT) scanner, the first of its kind in Canada. The machine will be used as a component of a stand-alone Rapid Access Chest Pain Clinic that will provide earlier prevention and life-saving treatment to cardiac patients.

Home June 20, 2019
Home
Technology | Artificial Intelligence

Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for the company's HealthICH product. The new clearance covers an artificial intelligence (AI) alert for intracranial hemorrhage (ICH), based on head computed tomography (CT) scans.

Home June 19, 2019
Home
News | Cardiovascular Ultrasound

DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's LVivo EF artificial intelligence (AI)-based solution that generates fully automated left ventricular ejection fraction (LVEF). EF is a main indicator in assessing the global function of the left ventricle. Presently, many readers quantify EF visually or trace endocardial borders that may not be well defined, yielding high variability among results. LVivo EF aims to substantially reduce this variability by generating objective, accurate and fast AI-based EF.

Home June 19, 2019
Home
News | Cath Lab

Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR), pressure distal/pressure aortic (Pd/Pa) alongside fractional flow reserve (FFR) post-percutaneous coronary intervention (PCI). This prospective study validates the diagnostic accuracy of Pd/Pa in identifying residual ischemia post-intervention against the reference standard, FFR. The study was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions, May 19-22 in Las Vegas.

Home June 19, 2019
Home
Technology | Defibrillator Monitors

Philips announced the U.S. Food and Drug Administration (FDA) has approved the company’s premarket approval (PMA) application for its HeartStart OnSite defibrillator (model M5066A) and HeartStart Home defibrillator (model M5068A). The approval includes the relevant supporting accessories, such as batteries and pad electrodes.

Home June 19, 2019
Home
Videos | Artificial Intelligence

Anthony Chang, M.D., chief artificial intelligence officer, Children’s Hospital of Orange County (CHOC), and founder ...

Home June 18, 2019
Home
News | Patient Monitors

New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense bleeding events during endovascular-related procedures by using sensors to detect relative changes in tissue bioimpedance. The study enrolled 60 patients from five sites who underwent an endovascular procedure and detected bleeding in more than half of patients. The results of this study were presented as late- breaking clinical research on at the Society for Cardiovascular Angiography Interventions (SCAI) 2019 Scientific Sessions, May 19-22 in Las Vegas.

Home June 18, 2019
Home
Subscribe Now